ATC 2010 Conference Review - Reviewed by Associate Professor Rowan Walker

In this review:

Proteasome inhibitor-based therapy for reduction of HLA sensitization
Peripheral neuropathy with bortezomib-based therapy
Alemtuzumab vs thymoglobulin and basiliximab in renal transplantation
Terminal complement inhibition decreases early AHR
Everolimus p

Please login below to download this issue (PDF)